HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael R McDevitt Selected Research

lintuzumab

1/2022Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.
11/2010Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.
8/2002Targeted alpha particle immunotherapy for myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael R McDevitt Research Topics

Disease

34Neoplasms (Cancer)
01/2021 - 08/2002
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2022 - 11/2010
4Prostatic Neoplasms (Prostate Cancer)
03/2022 - 01/2018
3Melanoma (Melanoma, Malignant)
08/2020 - 09/2017
3Breast Neoplasms (Breast Cancer)
01/2020 - 07/2004
2Neuroblastoma
01/2020 - 10/2004
2Inflammation (Inflammations)
01/2018 - 09/2005
2Glioblastoma (Glioblastoma Multiforme)
11/2016 - 10/2016
2Leukemia
03/2011 - 12/2002
2Myeloid Leukemia (Leukemia, Myelocytic)
11/2010 - 08/2002
2Carcinoma (Carcinomatosis)
03/2007 - 08/2003
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Testicular Neoplasms (Testicular Cancer)
09/2017
1Edema (Dropsy)
11/2016
1Brain Neoplasms (Brain Tumor)
10/2016
1Acute Kidney Injury (Acute Renal Failure)
03/2016
1Communicable Diseases (Infectious Diseases)
12/2013
1Lymphoma (Lymphomas)
03/2011
1Vascular Remodeling
11/2010
1Colonic Neoplasms (Colon Cancer)
10/2010
1Residual Neoplasm
03/2007

Drug/Important Bio-Agent (IBA)

9Radioisotopes (Radionuclides)IBA
01/2021 - 12/2002
7Pharmaceutical PreparationsIBA
01/2021 - 03/2007
6AntibodiesIBA
03/2022 - 07/2007
6IsotopesIBA
01/2021 - 08/2002
6Actinium-225IBA
08/2020 - 08/2003
6Carbon Nanotubes (Carbon Nanotube)IBA
01/2018 - 07/2007
41,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021 - 10/2010
4Monoclonal AntibodiesIBA
09/2014 - 08/2002
4cadherin 5IBA
11/2010 - 03/2007
3lintuzumabIBA
01/2022 - 08/2002
3Androgen Receptors (Androgen Receptor)IBA
01/2021 - 01/2018
3EpitopesIBA
09/2017 - 10/2010
2AcidsIBA
01/2021 - 10/2010
2Neoplasm Antigens (Tumor Antigens)IBA
01/2021 - 01/2020
2procaine isothiocyanate (PRIT)IBA
01/2021 - 01/2020
2RadiopharmaceuticalsIBA
11/2020 - 01/2020
2Melanocyte-Stimulating Hormones (MSH)IBA
08/2020 - 01/2020
2Type 1 Melanocortin ReceptorIBA
08/2020 - 01/2020
2Silicon Dioxide (Silica)FDA LinkGeneric
08/2020 - 01/2020
2RNA (Ribonucleic Acid)IBA
01/2020 - 01/2018
2AntigensIBA
01/2020 - 09/2017
2Prostate-Specific Antigen (Semenogelase)IBA
01/2020 - 03/2007
2Immunoglobulin G (IgG)IBA
01/2020 - 10/2004
2OligonucleotidesIBA
10/2013 - 12/2008
2Liposomes (Liposome)IBA
12/2010 - 02/2004
2E4G10 antibodyIBA
11/2010 - 10/2010
2LigandsIBA
05/2010 - 12/2008
2Immunoconjugates (Immunoconjugate)IBA
10/2004 - 08/2003
2Trastuzumab (Herceptin)FDA Link
07/2004 - 08/2003
1Proteins (Proteins, Gene)FDA Link
01/2021
1thiamine triphosphorate (TTP)IBA
01/2021
1Antineoplastic Agents (Antineoplastics)IBA
08/2020
1Peptides (Polypeptides)IBA
08/2020
1Lutetium-177IBA
01/2020
14- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
01/2020
1alpha-MSHIBA
01/2020
1Biological ProductsIBA
01/2020
1HaptensIBA
01/2020
1Cyclic PeptidesIBA
01/2020
1Contraceptive Agents (Contraceptives)IBA
01/2019
1Kallikreins (Kallikrein)IBA
01/2019
1Hormones (Hormone)IBA
01/2019
1Levonorgestrel (Plan B)FDA LinkGeneric
01/2019
1Tissue Kallikreins (Tissue Kallikrein)IBA
01/2019
1Testosterone (Sustanon)FDA Link
01/2019
1Dihydrotestosterone (Androstanolone)IBA
01/2019
1Tumor Biomarkers (Tumor Markers)IBA
09/2017
1Zirconium-89IBA
09/2017
1Angiogenesis InhibitorsIBA
11/2016
1Bevacizumab (Avastin)FDA Link
11/2016
1Dasatinib (BMS 354825)FDA Link
11/2016
1Platelet-Derived Growth FactorIBA
11/2016
1Therapeutic UsesIBA
10/2016
1Cadherins (E-Cadherin)IBA
10/2016
1NestinIBA
10/2016
1Small Interfering RNA (siRNA)IBA
03/2016
1Ammonium CompoundsIBA
03/2016
1VaccinesIBA
12/2013
1MorpholinosIBA
10/2013
1ActiniumIBA
10/2011
1Immunoglobulin M (IgM)IBA
03/2011
1Nucleotide AptamersIBA
03/2011
1Peptide Hydrolases (Proteases)FDA Link
03/2011
1Cytarabine (Cytosar-U)FDA LinkGeneric
11/2010
1Deferoxamine (Desferal)FDA LinkGeneric
10/2010
1Surface Antigens (Surface Antigen)IBA
05/2010
1Fluorescent Dyes (Fluorescent Probes)IBA
07/2007
1Oxygen (Dioxygen)IBA
03/2007
1Paclitaxel (Taxol)FDA LinkGeneric
03/2007
1Unithiol (DMPS)IBA
06/2005
1GD2 gangliosideIBA
10/2004

Therapy/Procedure

19Therapeutics
11/2020 - 08/2003
7Radioimmunotherapy
01/2021 - 08/2003
6Radiotherapy
01/2020 - 03/2007
4Immunotherapy
11/2010 - 08/2002
2Aftercare (After-Treatment)
01/2020 - 09/2005
2Drug Therapy (Chemotherapy)
11/2010 - 03/2007
1Castration
03/2022
1Precision Medicine
01/2021